You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALD

Showing 1 - 25 of 169
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

X-linked Adrenoleukodystrophy Trial in Leipzig (SMART-ALD, Waiting list)

Recruiting
  • X-linked Adrenoleukodystrophy
  • SMART-ALD
  • Waiting list
  • Leipzig, Saxony, Germany
  • +1 more
Aug 16, 2022

Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))

Recruiting
  • Cerebral Adrenoleukodystrophy
  • Mesenchymal stem cells (IV-MSC)
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Sep 7, 2023

Adrenomyeloneuropathy Trial (PXL770)

Not yet recruiting
  • Adrenomyeloneuropathy
  • (no location specified)
Feb 23, 2022

ALD (Adrenoleukodystrophy) Trial (PXL065)

Not yet recruiting
  • ALD (Adrenoleukodystrophy)
  • (no location specified)
Feb 23, 2022

Quantitative MRI for Non-invasive Assessment of Severity of

Active, not recruiting
  • Alcoholic Liver Disease
  • MRI
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Dec 14, 2021

Comparison of ALD, NASH, and Healthy Control Patients

Recruiting
  • ALD - Alcoholic Liver Disease
  • Blood draw
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Sep 9, 2021

ALD (Adrenoleukodystrophy), Adrenoleukodystrophy, Cerebral Adrenoleukodystrophy Trial in Minneapolis (Medical Record

Recruiting
  • ALD (Adrenoleukodystrophy)
  • +2 more
  • Medical Record Abstraction
  • Biospecimen Sample Collection
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 22, 2022

Non-alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Fibrosis Trial in France (eLIFT)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • +2 more
  • eLIFT
  • Angers, France
  • +5 more
Jan 26, 2023

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) Trial in United States (VK0214, Placebo)

Recruiting
  • Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)
  • Palo Alto, California
  • +3 more
Jul 19, 2022

Alterations of Gut Microbiota and Metabolites in ALD Patients

Recruiting
  • Liver Disease; Alcohol-Related
  • Gut Microbiota
  • Collect stool and blood samples from patients
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Jul 10, 2022

X-linked Adrenoleukodystrophy Trial in Palo Alto (vitamin D3)

Completed
  • X-linked Adrenoleukodystrophy
  • vitamin D3
  • Palo Alto, California
    Stanford University
Jun 6, 2022

Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug

Enrolling by invitation
  • Cerebral Adrenoleukodystrophy (CALD)
  • +2 more
  • Lenti-D
  • Los Angeles, California
  • +10 more
Nov 4, 2022

DENT IMPLANTS, LASER Trial in Houston (procedure, drug, device)

Recruiting
  • DENT IMPLANTS
  • LASER
  • Conventional mechanical therapy
  • +4 more
  • Houston, Texas
    University of Texas Health Science Center at Houston School of D
Oct 31, 2022

Vitrectomy, Cataract Trial in Paris (Objective Scatter Index (OSI), Average Lens Density (ALD))

Recruiting
  • Vitrectomy
  • Cataract
  • Objective Scatter Index (OSI)
  • Average Lens Density (ALD)
  • Paris, France
    Hôpital Fondation A. de Rothschuld
Oct 4, 2021

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting
  • AMN
  • +2 more
  • SBT101
  • Imitation Procedure
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Jun 1, 2022

Acute GvHD Trial in United States (ALD518)

Terminated
Has Results
  • Acute GvHD
  • ALD518
  • Duarte, California
  • +4 more
Feb 8, 2021

Development of BREATHE-ALD,Shared Decision-Making Intervention

Recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Interstitial
    • New York, New York
      CUIMC
    Dec 5, 2021

    Diagnosis and Treatment Management of Rare Neurological Disease

    Withdrawn
    • Xlsma
    • +3 more
      • Shanghai, China
        Children's Hospital of Fudan University
      Aug 4, 2021

      Migraine Trial in Melbourne (ALD1910, Sumatriptan)

      Completed
      • Migraine
      • ALD1910
      • Sumatriptan
      • Melbourne, Australia
        Nucleus Network Pty Ltd
      Sep 21, 2020

      X-linked Adrenoleukodystrophy Trial in Beijing

      Recruiting
      • X-linked Adrenoleukodystrophy
        • Beijing, China
          Beijing Tiantan Hospital
        Jul 2, 2023

        Oral Mucositis Trial in Worldwide (ALD518, 0.9% saline)

        Terminated
        Has Results
        • Oral Mucositis
        • ALD518
        • 0.9% saline
        • Clearwater, Florida
        • +30 more
        Apr 16, 2021

        The Natural History of Metachromatic Leukodystrophy

        Recruiting
        • MLD
        • +26 more
        • Palliative Care
        • Hematopoetic Stem Cell Transplantation
        • Pittsburgh, Pennsylvania
          The Program for the Study of Neurodevelopment in Rare Disorders,
        Nov 2, 2021

        Risk Behaviors in Adolescents With Chronic Diseases

        Recruiting
        • Chronic Disease
        • Somatic Disorders
        • Questionnaire risk behaviors in adolescents with chronic diseases
        • Paris, France
          Robert Debre Hospital
        Mar 20, 2023

        Alcoholic Liver Disease Trial in Chuncheon

        Active, not recruiting
        • Alcoholic Liver Disease
          • Chuncheon, Gangwondo, Korea, Republic of
            Department of Internal Medicine, Hallym University Chuncheon Sac
          Mar 19, 2023

          Alcohol Use Disorder, Alcoholic Liver Disease, Microbiome Trial in Los Angeles (VSL #3 112.5 Capsule, Placebo)

          Recruiting
          • Alcohol Use Disorder
          • +2 more
          • VSL #3 112.5 Capsule
          • Placebo
          • Los Angeles, California
            University of California, Los Angeles
          May 16, 2022